Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Seminars in Hematology|June 26, 2012
Management strategies for relapsed/refractory multiple myeloma: current clinical perspectivesAndrzej JakubowiakClinical Lymphoma, Myeloma & Leukemia|August 3, 2022
Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple MyelomaAjay Major, Andrzej Jakubowiak, Benjamin DermanBlood Reviews|September 4, 2021
Knowing the unknowns in high risk multiple myelomaBenjamin A Derman, Satyajit Kosuri, Andrzej JakubowiakLeukemia & Lymphoma|May 10, 2002
Cladribine underdosing in hairy-cell leukemia: a cause for apparent response failureDavid W Golde, Andrzej Jakubowiak, Janine Caggiano, et al.Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Reframing the Value of Treatments for Relapsed/Refractory Multiple MyelomaSikander Ailawadhi, Sumeet Panjabi, Marco Campioni, et al.Ejhaem|December 18, 2024
Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myelomaMarcus Marable, Kaitlin Kelly, Jennifer H Cooperrider, et al.Expert Review of Hematology|January 30, 2014
Current strategies for treatment of relapsed/refractory multiple myelomaJacob P Laubach, Peter M Voorhees, Hani Hassoun, et al.Leukemia|July 26, 2019
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myelomaOla Landgren, Pieter Sonneveld, Andrzej Jakubowiak, et al.Blood|April 26, 2008
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemiaLisa Kujawski, Peter Ouillette, Harry Erba, et al.Journal for Immunotherapy of Cancer|January 16, 2020
Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot studyBenjamin A Derman, Yuanyuan Zha, Todd M Zimmerman, et al.Pageof 7